Unite d'orthopédie et traumatologie du sport
Geneva, Canton of Geneva, 1232, Switzerland
NCT Number: NCT01994421
Background: Kinesiotaping (KT) is an elastic therapeutic tape developed in the 70's by Dr Kenso Kase for prevention and treatment of sports injuries. Research shows that through activation of skin receptors KT improves blood and lymph flow, increases proprioception, helps relieve pain, facilitates joint and muscle alignment, and enhances muscle function. Despite the increasing popularity of KT, uncertainty remains regarding, in particular, its effectiveness in improving strength.
Purpose: The purpose of the current study was to investigate the short-term effects of KT on muscle strength when applied to the quadriceps muscles of healthy subjects.
Methods: A randomized controlled trial with 52 healthy subjects was conducted. Subjects were tested under four different conditions: a) facilitating Kinesiotape, b) inhibiting Kinesiotape, c) classical tape with no elastic properties, and d) no-taping across four different sessions. The parameters of interest were: quadriceps and hamstrings maximal strength and power using vertical jump tests (squat jump and countermovement jump), and peak concentric and eccentric knee torque (using isokinetic test protocol).
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Not applicable
Geneva, Canton of Geneva, 1232, Switzerland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Week 1, week 2, week 3, and week 4
Time frame: Week 1, week 2, week 3, and week 4
University Hospital, Geneva
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details